Objectives
PHASE 1: To develop and externally validate global payer value messages and the associated evidence set for PRODUCT X
PHASE 2: To develop a robust global pricing and market access strategy for PRODUCT X
Scope
Methodology
Conduct focus groups and In-Depth-Interviews (IDIs) with key payer and provider stakeholders in scope markets to understand the evolving cell therapy landscape and identify unique opportunities and challenges that are relevant for “one-time” therapies.
Deliverables
- Outputs from internal workshops summarizing alignment among cross-functional stakeholders
- Refined value story and supporting exhibits for PRODUCT X
- Key learnings and actionable recommendations informing pricing and market access strategy
Illustrative Outputs
Impact
CBP provided an impactful value, access, and pricing strategy for a CAR T-cell therapy product to support successful launch given its differentiated clinical data and competitive space.